Gujarat Themis Biosyn Limited (BOM:506879)
334.75
-25.85 (-7.17%)
At close: Jan 20, 2026
Gujarat Themis Biosyn Revenue
Gujarat Themis Biosyn had revenue of 423.49M INR in the quarter ending September 30, 2025, with 21.98% growth. This brings the company's revenue in the last twelve months to 1.55B, up 0.74% year-over-year. In the fiscal year ending March 31, 2025, Gujarat Themis Biosyn had annual revenue of 1.51B, down -11.20%.
Revenue (ttm)
1.55B
Revenue Growth
+0.74%
P/S Ratio
22.12
Revenue / Employee
7.04M
Employees
221
Market Cap
34.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.51B | -190.22M | -11.20% |
| Mar 31, 2024 | 1.70B | 214.37M | 14.45% |
| Mar 31, 2023 | 1.48B | 335.31M | 29.19% |
| Mar 31, 2022 | 1.15B | 242.91M | 26.82% |
| Mar 31, 2021 | 905.63M | 54.38M | 6.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 21.70B |
| Neuland Laboratories | 15.33B |
| Shilpa Medicare | 13.43B |
| Bajaj HealthCare | 6.11B |
| Sudeep Pharma | 5.61B |
| NGL Fine-Chem | 4.08B |
| Infinium Pharmachem | 1.57B |
| Anlon Healthcare | 1.44B |
Gujarat Themis Biosyn News
- 3 months ago - Gujarat Themis Biosyn begins commercial production after major capacity expansion at Vapi facility - Business Upturn
- 9 months ago - Gujarat Themis Biosyn starts commercial production at new API plant in Vapi, Gujarat - Business Upturn
- 1 year ago - Themis Medicare shares surge nearly 2% following amalgamation announcement - Business Upturn